Revive Therapeutics Ltd RVVTF

joshuadbryson

I've been following this particular stock since Feb of 2019. I am not very good at technical analysis but I know this stock should double on or before March 2021. With that assumption is their anyone that can chart this stock and come to the same conclusion? Thanks in advance.

day0

These are some of my favorites. :-) Enjoy! The entire forecast is NOT financial advice. Please speak with multiple professional financial advisors and never invest more than you have available for investments; which can rapidly lose or gain value at different times. All comments below are also NOT financial advice! Please let the viewers know what you think...

day0

The long-position on revive is still reflecting a possible $0.719 or higher by 2022-01 . The potential can reach significantly higher than $0.719 and may have the ability to reach $1.00 by 2022-06 . By 2025-12 , the potential can be as high as $3.00. However, there may be the potential for rapid spikes as high as $13.00 by 2026-02 . DISCLAIMER: THIS...

day0

This forecast is not financial advice . Please be responsible and speak with professional financial advisors. Please do your own research and create your own opinions . All comments below are also not financial advice. Markets can shift both up and down and down and up, so please be very careful.

joshnaimer Pro

I am already in from an earlier stage, but after breaking out of this triangle upwards I see RVVTF going up back to 75 cents around. It broke out of consolidation and came back down to re test, but after breaking past the sturdy resistance it is now on route up!

lillybear Pro

Juice

day0

There appears to be a " possible " (this is not a guarantee) positive repeat correction from around $0.3963 to $0.536 within the next 16 to 60 days . In the recent press releases there have been a lot of valuation placed heavily on the price $0.50. Please read the press releases for oneself and make up one's own mind on the perception of the purchases and...

AlenCiken

UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19 www.globenewswire.com

CryptoFundManager Premium

REVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M. Some analists predict an Average Target Price of 2.36 usd. The indicators are bullish on most timeframes. Still a lot of room to grow, with that huge volume. If you are interested to test some amazing buy and sell indicators, which give the signal...